EoL-1
Export
acute myeloid (eosinophilic) leukemia
Cell Type:
Granulocyte
Tissue Origin:
blood
Species:
human
Research Area:
Cancer Research/Cell Biology
Immunotherapy / Hematology
Cell Characteristics:
Suspension
Transfection Information
Lonza Optimized Protocol
Optimization Guideline
Filter:
Any Substrate
Any Platform
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols
or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our
optimization strategy
to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Protocol
Kit
Program
Cells
Efficiency
Viable Cells
Substrate
Format
Platform
V
G-016
3e6
56%
57%
Plasmid (general)
2 µg
100 µl
I/II/2b
V
G-010
3e6
41%
84%
Plasmid (general)
2 µg
100 µl
I/II/2b
V
G-012
3e6
49%
79%
Plasmid (general)
2 µg
100 µl
I/II/2b
V
O-005
3e6
69%
74%
Plasmid (general)
2 µg
100 µl
I/II/2b
Citations
A novel human anti-VCAM-1 monoclonal antibody ameliorates airway inflammation and remodelling.
Categories:
Primary Cells and Media, Classical Media and Reagents, Serum-free and Speciality Media
Authors:
Lee JH, Sohn JH, Ryu SY, Hong CS, Moon KD, Park JW
In:
J Cell Mol Med (2013) 17(10): 1271-81